• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
Nairametrics
No Result
View All Result
Home Spotlight

WHO prioritizes access to diabetes and cancer treatments in new Essential Medicines Lists

Chidinma Anyalewechi by Chidinma Anyalewechi
October 2, 2021
in Spotlight
WHO warns countries against rushing to lift coronavirus restrictions

Tedros Adhanom Ghebreyesus

Share on FacebookShare on TwitterShare on Linkedin

The World Health Organization (WHO) has published a new edition of its Model Lists of Essential Medicines and Essential Medicines for Children. This list includes new treatments for various cancers, insulin analogues and new oral medicines for diabetes, new medicines to assist people who want to stop smoking, and new antimicrobials to treat serious bacterial and fungal infections.

This move by the health organization aims to address global health priorities, to assist in identifying medicines with the highest benefits and at the same time, is available and affordable for all. However, the WHO affirms that high prices for both new, patented medicines and older medicines, continue to keep essential medicines out of reach for many patients.

In the news release, the WHO Director-General, Dr Tedros Adhanom Ghebreyesus said that “Diabetes is on the rise globally, and rising faster in low- and middle-income countries. Too many people who need insulin encounter financial hardship in accessing it or go without it and lose their lives. Including insulin analogues in the Essential Medicines List, coupled with efforts to ensure affordable access to all insulin products and expand use of biosimilars, is a vital step towards ensuring everyone who needs this life-saving product can access it.”

RelatedStories

polio immunization

WHO, UNICEF warn of rising immunization gaps as nearly 20 million infants missed vaccination in 2024 

July 15, 2025
WHO , EG.5 coronavirus variant, US, China

WHO backs global use of twice-yearly Lenacapavir Injection for HIV prevention

July 15, 2025

Why this is important

According to the WHO, the move to list long-acting insulin analogues and cancer treatments and drugs is intended to increase access to diabetes and cancer treatment by expanding the choice of treatment.

This is important especially considering that Insulin production is concentrated in a small number of manufacturing facilities, and three manufacturers control most of the global market, with the lack of competition resulting in high prices that are prohibitive for many people and health systems, the news release said.

The organization has recognized that cancers are among the leading causes of illness and death worldwide which accounted for nearly 10 million deaths in 2020, with seven out of 10 occurring in low- and middle-income countries.

For cancers, new breakthroughs have been made in cancer treatment in the last years, the WHO said, which includes medicines that target specific molecular characteristics of the tumour, some of which offer much better outcomes than “traditional” chemotherapy for many types of cancer.

The news release reads that “Four new medicines for cancer treatment were added to the Model Lists: Enzalutamide, as an alternative to abiraterone, for prostate cancer; Everolimus, for subependymal giant cell astrocytoma (SEGA), a type of brain tumour in children; Ibrutinib, a targeted medicine for chronic lymphocytic leukaemia; and Rasburicase, for tumour lysis syndrome, a serious complication of some cancer treatments.”

“The listing for imatinib was extended to include targeted treatment of leukaemia. New childhood cancer indications were added for 16 medicines already listed, including for low-grade glioma, the most common form of brain tumour in children.”

The World Health Organization (WHO) Model Lists are updated every two years by an Expert Committee, and the Committee is made up of recognized specialists from academia, research and the medical and pharmaceutical professions.

Tags: CancerDiabetesDr Tedros Adhanom GhebreyesusWHOWorld Health Organization
Chidinma Anyalewechi

Chidinma Anyalewechi

For further inquiries about this article, contact: Email: chidinma.anyalewechi@nairametrics.com LinkedIn: linkedin.com/in/chidinma-anyalewechi-a323ab173/

Related Posts

polio immunization
Health

WHO, UNICEF warn of rising immunization gaps as nearly 20 million infants missed vaccination in 2024 

July 15, 2025
WHO , EG.5 coronavirus variant, US, China
Health

WHO backs global use of twice-yearly Lenacapavir Injection for HIV prevention

July 15, 2025
WHO,
Health

WHO pushes for 50% health tax hike on tobacco, alcohol, sugary drinks globally to curb chronic diseases

July 3, 2025
Global leaders pledge over $170 million to WHO in push for sustainable health financing 
Health

Global leaders pledge over $170 million to WHO in push for sustainable health financing 

May 21, 2025
WHO nominates Prof. Mohamed Janabi as regional director for Africa 
Health

WHO nominates Prof. Mohamed Janabi as regional director for Africa 

May 19, 2025
WHO, Dr. Tedros Ghebreyesus,
Health

WHO downsizes workforce, cuts departments, and leadership roles amid financial constraints 

May 15, 2025
Next Post
Naira scarcity: LCCI warns Businesses suffering consequences of “currency policy lapses”

Independence: Innovative ways needed to fund Nigeria’s infrastructure – LCCI

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

first bank








DUNS

Recent News

  • FirstHoldco shares surge over 20% amid Otudeko’s exit in N323bn deal 
  • Lagos Govt, unions agree on N10,000 e-call-up fee for trucks on Lekki-Epe corridor, effective August 1 
  • Top 10 most affordable states to live in Nigeria – June 2025 ranking  

Follow us on social media:

Recent News

FBNH

FirstHoldco shares surge over 20% amid Otudeko’s exit in N323bn deal 

July 17, 2025
Lagos Govt, unions agree on N10,000 e-call-up fee for trucks on Lekki-Epe corridor, effective August 1 

Lagos Govt, unions agree on N10,000 e-call-up fee for trucks on Lekki-Epe corridor, effective August 1 

July 17, 2025
  • iOS App
  • Android App
  • Contact Us
  • Home
  • Markets
  • Sectors
  • Economy
  • Business News
  • Financial Literacy
  • Disclaimer
  • Ads Disclaimer
  • Copyright Infringement

© 2025 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Login
  • Sign Up

© 2025 Nairametrics